Search Results - "Juneau, D."

Refine Results
  1. 1

    N-Terminal Lipid Modification Is Required for the Stable Accumulation of CyanoQ in Synechocystis sp. PCC 6803 by Juneau, Andrea D, Frankel, Laurie K, Bricker, Terry M, Roose, Johnna L

    Published in PloS one (22-09-2016)
    “…The CyanoQ protein has been demonstrated to be a component of cyanobacterial Photosystem II (PS II), but there exist a number of outstanding questions…”
    Get full text
    Journal Article
  2. 2

    Is end-organ surveillance necessary in patients with well-functioning metal-on-metal hip resurfacings?: a cardiac MRI study by Juneau, D, Grammatopoulos, G, Alzahrani, A, Thornhill, R, Inacio, J R, Dick, A, Vogel, K I, Dobransky, J, Beaulé, P E, Dwivedi, G

    “…AimsCardiac magnetic resonance (CMR) was used to assess whether cardiac function or tissue composition was affected in patients with well-functioning…”
    Get full text
    Journal Article
  3. 3

    Molecular Imaging of Cardiac Sarcoidosis by Martineau, P., Pelletier-Galarneau, M., Juneau, D., Leung, E., Birnie, D., Beanlands, R. S. B.

    Published in Current cardiovascular imaging reports (01-03-2018)
    “…Purpose of Review Cardiac involvement is increasingly being recognized as a cause of significant morbidity and mortality in patients with sarcoidosis…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Exposure of environmental trace elements in prostate cancer patients: A multiple metal analysis by Tyagi, Bhawna, Chandrasekaran, Balaji, Tyagi, Ashish, Shukla, Vaibhav, Saran, Uttara, Tyagi, Neha, Talluri, Sriharsha, Juneau, Andrea D., Fu, Hangcheng, Ankem, Murali K., Damodaran, Chendil

    Published in Toxicology and applied pharmacology (15-11-2023)
    “…Prostate cancer (PCa) is the second leading cause of cancer-related deaths among men. To elucidate the connection between trace elements (arsenic: As, cadmium:…”
    Get full text
    Journal Article
  7. 7
  8. 8

    A First-in-Human Study of the Radiopharmaceutical [225Ac]-FPI-2068 in Patients (pts) with Advanced Solid Tumors by Ulaner, G.A., Juloori, A., Burns, T., Juneau, D., Iagaru, A.H., Schindler, J., Allan, S., Jean-Louis, L., Lunger, G.J., Nawine, M., Mueller, N., Littlewood, G., Trigg, W.

    “…The epidermal growth factor receptor (EGFR) and mesenchymal-epidermal transition tyrosine kinase receptor (c-MET) are frequently upregulated and co-expressed…”
    Get full text
    Journal Article
  9. 9

    F18-DCFPyL PSMA-PET/CT vs. mpMRI for Localizing the Gross Target Volume for Radiotherapy in Prostate Cancer by Belliveau, C., Benhacene-Boudam, M.K., Juneau, D., Olivié, D., Barkati, M., Delouya, G., Taussky, D., Lambert, C., Beauchemin, M.C., Menard, C.

    “…Local recurrences in prostate cancer (Pca) after radiotherapy generally occur in the site of dominant tumor burden, and recent evidence based on multi…”
    Get full text
    Journal Article
  10. 10
  11. 11

    PROGNOSTIC VALUE OF PET MPI MYOCARDIAL FLOW RESERVE IN CABG PATIENTS by Soltani, I, Chatta, R, Potter, B, Matteau, A, Juneau, D, Mansour, S

    Published in Canadian journal of cardiology (01-10-2021)
    “…Positron emission tomography (PET) myocardial perfusion imaging (MPI) is a well-validated non-invasive imaging technique for the assessment of coronary artery…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20